开能健康（300272）8月13日主力资金净流出1309.67万元

Core Viewpoint - As of August 13, 2025, Kaineng Health (300272) experienced a stock price decline of 4.64%, closing at 6.78 yuan, with significant trading activity and net outflow of funds [1] Financial Performance - For Q1 2025, Kaineng Health reported total revenue of 405 million yuan, reflecting a year-on-year growth of 6.31% - The net profit attributable to shareholders was 24.81 million yuan, up 11.30% year-on-year - The non-recurring net profit was 23.99 million yuan, showing a 17.06% increase year-on-year - The company's liquidity ratios include a current ratio of 1.234 and a quick ratio of 1.012, with a debt-to-asset ratio of 55.60% [1] Company Overview - Kaineng Health Technology Group Co., Ltd. was established in 2001 and is based in Shanghai, primarily engaged in the manufacturing of specialized equipment - The company has a registered capital of approximately 5.77 billion yuan and a paid-in capital of about 1.95 billion yuan - The legal representative of the company is Qu Jianguo [1] Investment and Intellectual Property - Kaineng Health has made investments in 20 enterprises and participated in 42 bidding projects - The company holds 202 trademark registrations and 412 patents, along with 331 administrative licenses [2]